The Role of FLT3 Kinase as an AML Therapy Target

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|18|19|2758-2765

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.18, Iss.19, 2012-06, pp. : 2758-2765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract